Some of the stocks that may grab investor focus today are:
- Alibaba Group Holdings Ltd BABA announced plans to raise its stock buyback program by an additional $4 billion. The company’s share repurchase program will now target a $10 billion buyback through the end of 2022. The higher magnitude of the repurchase limit comes at a time when the Alibaba stock has taken a hit due to the anti-competition probes from Chinese authorities. Alibaba shares dropped 13.3% to close at $222.00 on Thursday.
- AstraZeneca Plc’s AZN Covid-19 vaccine could receive approval in the United Kingdom as early as Tuesday, according to the Financial Times. AstraZeneca shares fell 0.1% to $48.51 in the after-hours trading session.
- Wall Street expects Weibo Corp WB to report quarterly earnings at $0.60 per share on revenue of $449.26 million before the opening bell. Weibo shares gained 0.5% to $44.54 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Choosing the best broker is an important part of being a successful trader or investor
- Orphazyme A/S ADR ORPH disclosed that the FDA has extended the review period of the NDA for arimoclomol for the treatment of Niemann-Pick Disease Type C by three months. Orphazyme shares gained 0.3% to close at $12.03 on Thursday.
- Bayerische Motoren Werke ADR BMWYY announced plans to increase its projected output for electric cars by about 250,000 units in the next two years. BMW shares rose 0.2% to close at $29.95 on Thursday.
Loading...
Loading...
AZNAstraZeneca PLC
$70.37-0.83%
Edge Rankings
Momentum
50.36
Growth
82.30
Quality
59.52
Value
21.40
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in